ARC
BIIB icon

Absolute Return Capital’s Biogen BIIB Stock Holding History

Absolute Return Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,765
Closed -$1.12M – 515
2015
Q2 		$1.12M Buy
+2,765
New +$1.11M 0.04% 328

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Absolute Return Capital's BIIB Position: Q3 2015 in Review

Absolute Return Capital sold out of Biogen (BIIB) in Q3 2015, closing a stake of 2,765 shares — an estimated $1.12M sold.

Absolute Return Capital first reported a position in BIIB in Q2 2015 and held it in 1 quarter. The position peaked at $1.12M in Q2 2015. 923 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Absolute Return Capital reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
  • Absolute Return Capital sold 2,765 Biogen shares in Q3 2015, an estimated $1.12M.
  • Absolute Return Capital first reported a position in Biogen in Q2 2015 and held it in 1 quarter.
  • Absolute Return Capital's Biogen position peaked at $1.12M in Q2 2015.
  • 923 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Absolute Return Capital's 13F filing for Q3 2015, filed 13 Nov 2015.